SONOMA PHARMACEUTICALS, INC. (SNOA) Operating income 2017–2026
SONOMA PHARMACEUTICALS, INC. (SNOA) annual operating income history from SEC filings — each fiscal year as reported.
-$2.5MFY2026 · since FY2017: -$13.0M → -$2.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$2.5M | +33.7% |
| FY2025 | -$3.7M | +21.1% |
| FY2024 | -$4.7M | -2.9% |
| FY2023 | -$4.6M | +22.4% |
| FY2022 | -$5.9M | -70.7% |
| FY2021 | -$3.4M | +53.3% |
| FY2020 | -$7.4M | +34.4% |
| FY2019 | -$11.3M | +20.7% |
| FY2018 | -$14.2M | -9.4% |
| FY2017 | -$13.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SNOA financial trends
SNOA RevenueSNOA Net incomeSNOA Net marginSNOA Gross profitSNOA Gross marginSNOA Operating marginSNOA Operating cash flowSNOA Free cash flowSNOA Capital expendituresSNOA Return on equitySNOA Stock buybacksSNOA Dividends paidSNOA Total assetsSNOA Total liabilitiesSNOA Shareholders’ equitySNOA overview →